Back to search

Article

A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities

2024-05-21

Abstract excerpt

Abstract Incretin mimetics, also known as glucagon-like peptide-1 (GLP-1) receptor agonists, are a class of medications used to treat type 2 diabetes by mimicking the actions of incretin hormones in the body. These hormones are responsible for promoting insulin release from the pancreas in response to nutrient intake, as well as decreasing glucagon secretion, slowing gastric emptying, and promoting satiety. By imi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0fda1d8b-e21e-504a-ae8e-9b4eb90a9c7c
DOI
10.20944/preprints202405.1369.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated ComorbiditiesDOI 10.20944/preprints202405.1369.v1
Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.Semantic proximity
A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulationSemantic proximity
Modern Hypoglycemic Agents and Their Perioperative ImplicationsSemantic proximity
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Semantic proximity
Recent advances in understanding the role of glucagon-like peptide 1Semantic proximity
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.Semantic proximity
A review of nateglinide in the management of patients with type 2 diabetes.Semantic proximity
Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.Semantic proximity
The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity
Current therapies and targets for type 2 diabetes mellitusSemantic proximity
[Management of the MODY type diabetes].Semantic proximity
Advances in Diagnosis and Management of Diabetes in Children and Adults with Focus on Drugs, Insulin, and Dietary InterventionsSemantic proximity
Select a neighboring publication to make it the new centre.